Medpace Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,678	2,530	2,109	1,886	1,460	1,142
Revenue Growth (YoY)	24.19%	19.97%	11.84%	29.17%	27.80%	23.38%
Cost of Revenue	1,900	1,770	1,453	1,361	1,028	814.22
Gross Profit	778.59	760.62	656.31	524.51	432.44	328.16
Selling, General & Admin	187.58	197.56	180.18	161.35	131.4	108.42
Depreciation & Amortization Expenses	28.1	28.12	29.25	26.33	22.34	21.12
Total Operating Expenses	215.68	225.68	209.44	187.68	153.74	129.54
Operating Income	562.92	534.94	446.87	336.83	278.7	198.62
Interest Income	11.43	12.78	25	-0.49	-2.91	-0.11
Other Non-Operating Income (Expense)	-2.55	-5.34	4.06	-0.66	7.07	3.34
Total Non-Operating Income (Expense)	8.88	7.44	29.05	-1.14	4.16	3.24
Pretax Income	571.8	542.38	475.92	335.68	282.86	201.85
Provision for Income Taxes	111.4	91.25	71.54	52.87	37.49	20
Net Income	460.4	451.12	404.39	282.81	245.37	181.85
Net Income to Common	460.4	451.12	404.39	282.81	245.37	181.85
Net Income Growth	10.57%	11.56%	42.99%	15.26%	34.93%	25.08%
Shares Outstanding (Basic)	28	29	31	31	32	36
Shares Outstanding (Diluted)	29	30	32	32	34	38
Shares Change (YoY)	-8.93%	-7.77%	0.54%	-5.44%	-10.68%	-0.03%
EPS (Basic)	16.24	15.64	13.06	9.20	7.57	5.06
EPS (Diluted)	15.91	15.28	12.63	8.88	7.28	4.81
EPS Growth	21.45%	20.98%	42.23%	21.98%	51.35%	25.26%
Shares Outstanding	28.56	28.37	30.63	30.75	31.09	36.01
Free Cash Flow	711	681.87	572.27	396.73	351.17	235.06
Free Cash Flow Growth	4.27%	19.15%	44.25%	12.97%	49.40%	3.40%
Free Cash Flow Per Share	24.54	23.09	17.88	12.46	10.43	6.24
Gross Margin	29.07%	30.06%	31.12%	27.81%	29.62%	28.73%
Operating Margin	21.02%	21.14%	21.19%	17.86%	19.09%	17.39%
Profit Margin	17.19%	17.83%	19.17%	15.00%	16.81%	15.92%
FCF Margin	26.55%	26.95%	27.13%	21.04%	24.05%	20.58%
EBITDA	591.02	563.06	476.12	363.15	301.04	219.73
EBITDA Margin	22.07%	22.25%	22.58%	19.26%	20.62%	19.23%
EBIT	562.92	534.94	446.87	336.83	278.7	198.62
EBIT Margin	21.02%	21.14%	21.19%	17.86%	19.09%	17.39%
Effective Tax Rate	19.48%	16.82%	15.03%	15.75%	13.25%	9.91%

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q